UK Contraceptive Devices Market Report 2022 to 2030

UK Contraceptive Devices Market Analysis

$ 3999

UK's Contraceptive Devices Market is expected to witness growth from $335 Mn in 2022 to $535 Mn in 2030 with a CAGR of 6.00% for the forecasted year 2022-30. In the UK, people are becoming more aware of and accepting of contraceptive methods. Individuals are more likely to utilize contraceptives to avoid unwanted pregnancies as they become more aware of their alternatives. The market is segmented by type and by gender. Some key players in this market include Consilient Health, Renovos Biologics, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.

ID: IN10GBMD005 CATEGORY: Medical Devices GEOGRAPHY: UK AUTHOR: Jigyasu Bhandari

Buy Now

UK Contraceptive Devices Healthcare Market Executive Analysis

UK's Contraceptive Devices Market is expected to witness growth from $335 Mn in 2022 to $535 Mn in 2030 with a CAGR of 6.00% for the forecasted year 2022-30. Healthcare made up roughly 46.79% of the total cost of all the goods and services the UK government acquired in 2023. The average individual contributes roughly 18% of their income in income tax, or 4.5% of their income, for healthcare. The entire cost of contemporary healthcare was $273.69 billion in 2022 or $4168.95 per person. In 2021, the UK's overall current healthcare spending grew from 9.9% to 10.2% of GDP compared to 2018.

In the UK, there were 251 maternal deaths between 2018 and 2022, with a maternal mortality rate of 11.7 per 100,000 live births. In England, there were 468,342 diagnoses of sexually transmitted infections in 2022. To stop sperm from accessing and fertilizing an egg, contraceptive methods including condoms, diaphragms, intrauterine devices, contraceptive implants, and contraceptive patches can help prevent unexpected births. To control menstrual cycles and lessen discomfort and bleeding, some contraceptive methods—such as hormonal IUDs and contraceptive pills—can be used. Certain contraceptive methods, including hormonal IUDs, contraceptive pills, and patches, can lower the chance of developing conditions like ovarian and endometrial cancer, pelvic inflammatory disease, and ectopic pregnancy.

UK Contraceptive Devices Market Analysis

Market Dynamics

Market Growth Drivers

In the UK, people are becoming more aware of and accepting of contraceptive methods. Individuals are more likely to utilise contraceptives to avoid unwanted pregnancies as they become more aware of their alternatives. In the UK, as more people look to control their reproductive health, the population is expanding and the country is becoming more urbanised, which has increased the demand for contraceptives. Contraceptive development has benefited from technological improvements as new and inventive solutions have been produced, giving consumers additional choices. The use of contraceptives has increased as a result of people's changing lifestyles in the UK, which include postponing marriage, focusing more on careers, and engaging in more sexual activity outside of traditional relationships.

Market Restraints

In the UK, some contraceptive methods might be pricey, which might be a deterrent for people with low incomes. This can restrict overall demand for these gadgets and have an effect on market expansion. Some contraceptive methods, especially hormonal ones, can cause unwanted side effects like weight gain, depressive symptoms, and acne. Certain forms of contraceptives may become less popular and in demand as a result of these negative effects. Access to contraceptive methods and healthcare professionals who can advise on their usage may be restricted in some parts of the UK. The overall demand for these gadgets may be impacted by this.

Competitive Landscape

Key Players

Consilient Health (UK)
Renovos Biologics (UK)
Mylan Laboratories
CooperSurgical
Pfizer
Teva Pharmaceutical

Healthcare Policies and Regulatory Landscape

The UK's regulatory body, the Medicines and Healthcare Products Regulatory Agency (MHRA) is in charge of ensuring that drugs, medical equipment, and blood components are suitable for use by the general public. In the UK, contraceptive devices are governed by the MHRA, which makes sure they adhere to strict performance and safety requirements. The UK's National Health Service (NHS) is guided by the National Institute for Health and Care Excellence (NICE), an independent body. NICE offers advice on the use of contraceptive techniques, including suggestions for the best and most affordable options. The Faculty of Sexual and Reproductive Healthcare (FSRH) has designed a programme called Contraception Education and Training for Healthcare Professionals (CET) that instructs medical staff members on how to offer contraceptive products and services. The programme seeks to guarantee that medical practitioners have the knowledge and abilities needed to offer people in the UK high-quality contraceptive care.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Contraceptive Devices Market Segmentation

By Type (Revenue, USD Billion):

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS, per the World Health Organization Updates in November 2020. To a lesser extent, they also protect against genital herpes, human papillomavirus (HPV), and syphilis. Hence, the other reasons that aid the growth of the contraception devices market are the rising occurrence of STDs and the substantial increase in the population

Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Devices (IUD)
Other Devices

By Gender (Revenue, USD Billion):

Based on Gender the contraceptive devices market is segmented into male and female.

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.